Intermittent Administration of Parathyroid Hormone 1-34 Enhances Osteogenesis of Human Mesenchymal Stem Cells by Regulating Protein Kinase Cδ.

about

Intermittent Administration of Parathyroid Hormone 1-34 Enhances Osteogenesis of Human Mesenchymal Stem Cells by Regulating Protein Kinase Cδ.

Item

http://www.wikidata.org/entity/Q47161270

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Intermittent Administration of ...... Regulating Protein Kinase Cδ.

@en

Intermittent Administration of ...... Regulating Protein Kinase Cδ.

@nl

type

Item

label

Intermittent Administration of ...... Regulating Protein Kinase Cδ.

@en

Intermittent Administration of ...... Regulating Protein Kinase Cδ.

@nl

prefLabel

Intermittent Administration of ...... Regulating Protein Kinase Cδ.

@en

Intermittent Administration of ...... Regulating Protein Kinase Cδ.

@nl

P1476

Intermittent Administration of ...... Regulating Protein Kinase Cδ.

@en

P2093

Marilyn G Rimando

http://www.w3.org/2001/XMLSchema#string

Oscar K Lee

http://www.w3.org/2001/XMLSchema#string

Shu-Wen Kuo

http://www.w3.org/2001/XMLSchema#string

P2860

The extended protein kinase C superfamily

PTH receptor-1 signalling-mechanistic insights and therapeutic prospects

Catabolic and anabolic actions of parathyroid hormone on the skeleton

Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone

Molecular cloning and characterization of a parathyroid hormone/parathyroid hormone-related peptide receptor: a member of an ancient family of G protein-coupled receptors

Effects of intermittent versus continuous parathyroid hormone administration on condylar chondrocyte proliferation and differentiation

The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Parathyroid hormone: anabolic and catabolic actions on the skeleton

Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis

P31

scholarly article

P356

10.3390/IJMS18102221

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yi-Shiuan Liu

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29064396

http://www.w3.org/2001/XMLSchema#string

P932

5666900

http://www.w3.org/2001/XMLSchema#string